Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Online sales of weight-loss drugs, including WeGovy and Mounjaro, have been criticised since they were introduced. The World ...